The Return of Vaccines - The Scientist - Magazine of the Life Sciences

Supplements

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

Institutions

For Advertisers

by Susan Warner

BIOBUSINESS

The Return of Vaccines

Why is Big Pharma investing in a market they once spurned?

Email: Susan Warner - swarner@the-scientist.com
The Scientist 2005, 19(22):28

Published

21 November 2005

Last December, as the flu season approached, Wyeth Pharmaceuticals' influenza vaccine plant in rural Lancaster County, Pa., stood abandoned. The site had produced vaccines since 1882, but after suffering four money-losing years, Wyeth pulled out of the flu business in 2003. Contrast that with this year: The plant has a new owner, rival drug maker GlaxoSmithKline (GSK), which along with other large pharmaceutical firms is increasing its stake in vaccines. By 2010, the British drug maker expects to open a new cutting-edge vaccine plant in Marietta, Pa., using tissue-based technology.


	The article you are attempting to read is Premium content which is only available to our online subscribers.

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today